Alessandro Capone

Medicine & Life Sciences

1. Italy 100%
2. ceftazidime drug combination avibactam 88%
3. Infections 74%
4. Klebsiella pneumoniae 72%
5. carbapenemase 69%
6. Carbapenems 50%
7. Intensive Care Units 47%
8. Acinetobacter baumannii 46%
9. Daptomycin 42%
10. Plasmids 40%
11. HIV 39%
12. Anti-Bacterial Agents 38%
13. Methicillin-Resistant Staphylococcus aureus 35%
14. Staphylococcus aureus 28%
15. Therapeutics 28%
16. Pregnant Women 27%
17. Pregnancy Outcome 26%
18. Endocarditis 26%
19. Cutaneous anthrax 26%
20. Klebsiella Infections 26%
21. keratinocyte growth factor receptor 26%
22. Observational Studies 25%
23. Staphylococcal Infections 23%
24. Invasive Candidiasis 23%
25. galantide 23%
26. Citrobacter freundii 22%
27. Hereditary Hemorrhagic Telangiectasia 21%
28. Teicoplanin 21%
29. Anthrax 20%
30. Skin 20%
31. Tigecycline 20%
32. Enterobacter cloacae 20%
33. Carbapenem-Resistant Enterobacteriaceae 20%
34. Croatia 19%
35. Genes 19%
36. Bacteremia 19%
37. Colistin 19%
38. CD4-CD8 Ratio 18%
39. Salvage Therapy 18%
40. Mortality 17%
41. Quinolones 17%
42. Pregnancy 17%
43. Ciprofloxacin 16%
44. Brain Abscess 16%
45. Critical Care 16%
46. Glycopeptides 16%
47. Candida 15%
48. Oxacillin 15%
49. Meningitis 15%
50. Clone Cells 14%